Daniel  Brinton  to  Mucocutaneous Lymph Node Syndrome
                            
                            
                                This is a "connection" page, showing publications  Daniel  Brinton  has written about  Mucocutaneous Lymph Node Syndrome.
                            
                            
                            
                                
                                    
                                            
    
        
        
        
            Connection Strength
            
                
            
            0.352
         
        
        
     
 
    
        
        - 
            Assessing Health Care Utilization and Compliance in Kawasaki Disease. J Pediatr. 2021 Jul; 234:181-186.e1.
            
            
                Score: 0.178
            
         
        
        - 
            A Cost Comparison of Infliximab Versus Intravenous Immunoglobulin for Refractory Kawasaki Disease Treatment. Hosp Pediatr. 2021 01; 11(1):88-93.
            
            
                Score: 0.174